Everolimus in cardiac-transplant recipients.
作者信息
Banas Bernhard, Böger Carsten, Krämer Bernhard
出版信息
N Engl J Med. 2003 Dec 4;349(23):2271-2; author reply 2271-2. doi: 10.1056/NEJM200312043492322.
PMID:14657441
Abstract
摘要
相似文献
1
Everolimus in cardiac-transplant recipients.依维莫司用于心脏移植受者。
N Engl J Med. 2003 Dec 4;349(23):2271-2; author reply 2271-2. doi: 10.1056/NEJM200312043492322.
2
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.依维莫司预防心脏移植受者的移植物排斥和血管病变。
N Engl J Med. 2003 Aug 28;349(9):847-58. doi: 10.1056/NEJMoa022171.
3
From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.从临床试验到临床实践：心脏移植中Certican（依维莫司）概述
J Heart Lung Transplant. 2005 Apr;24(4 Suppl):S185-90; discussion S210-1. doi: 10.1016/j.healun.2005.01.013.
4
Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis.依维莫司预防心脏移植受者急性排斥反应和移植血管病变：一项24个月的分析
J Heart Lung Transplant. 2007 Jun;26(6):584-92. doi: 10.1016/j.healun.2007.03.005. Epub 2007 Apr 27.
5
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial.用Certican（依维莫司）预防心脏移植血管病变：斯坦福大学在Certican III期临床试验中的经验。
J Heart Lung Transplant. 2005 Apr;24(4 Suppl):S191-5; discussion S210-1. doi: 10.1016/j.healun.2005.01.012.
6
Long-term cardiovascular risk in transplantation--insights from the use of everolimus in heart transplantation.移植中的长期心血管风险——依维莫司在心脏移植中的应用见解
Nephrol Dial Transplant. 2006 Jul;21 Suppl 3:iii9-13. doi: 10.1093/ndt/gfl295.
7
Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.德国柏林心脏中心对初发心脏移植患者使用Certican（依维莫司）的临床经验。
J Heart Lung Transplant. 2005 Apr;24(4 Suppl):S201-5; discussion S210-1. doi: 10.1016/j.healun.2005.01.011.
8
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.心脏移植受者的药物治疗：第二部分：免疫抑制药物
Circulation. 2004 Dec 21;110(25):3858-65. doi: 10.1161/01.CIR.0000150332.42276.69.
9
Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference.
J Heart Lung Transplant. 2007 Apr;26(4):305-11. doi: 10.1016/j.healun.2007.01.010.
10
Everolimus: efficacy and safety in cardiac transplantation.依维莫司：在心脏移植中的疗效和安全性。
Expert Opin Drug Saf. 2010 Sep;9(5):843-54. doi: 10.1517/14740338.2010.511611.
引用本文的文献
1
Everolimus.
Drugs. 2004;64(8):861-72; discussion 873-4. doi: 10.2165/00003495-200464080-00005.
Zotero 插件